| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/21/2009 | CA2362518C Heat-inducible promoter |
| 04/21/2009 | CA2341050C Nucleic acid sequence for potentiating the expression of useful gene and method therefor |
| 04/21/2009 | CA2265976C High level expression of proteins |
| 04/21/2009 | CA2231603C Chicken interleukin-15 and uses thereof |
| 04/21/2009 | CA2193641C 66 kda antigen from borrelia |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/21/2009 | CA1341593C Process for the production of protein products in aspergillus oryzae anda promoter for the use in aspergillis |
| 04/16/2009 | WO2009049274A2 Microorganism engineered to produce isopropanol |
| 04/16/2009 | WO2009048072A1 ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN Siglec-15 |
| 04/16/2009 | WO2009048067A1 Genetically engineered blood coagulation factor x having no sugar chain, and method for production thereof |
| 04/16/2009 | WO2009047311A1 Chemo-enzymatic peptide synthesis via c-terminal ester interconversion |
| 04/16/2009 | WO2009046618A1 Deshydroxy vancomycin, the preparation, pharmaceutical composition and the use |
| 04/16/2009 | WO2009012173A3 Enhanced biotherapeutic production using inhibitory rna |
| 04/16/2009 | WO2008028002A9 Increasing nadph-dependent products |
| 04/16/2009 | WO2008027252A3 Poxvirus ifn- ybp c-terminal domain |
| 04/16/2009 | WO2007111628A3 Mxa as an antiviral drug and as a target for identification of antiviral drugs for dna virus infections |
| 04/16/2009 | WO2007028070A3 Use of soluble flt-1 and its fragments in cardiovascular conditions |
| 04/16/2009 | WO2007021733A3 Methods and compositions for enhancing protein folding |
| 04/16/2009 | WO2007019064A3 ANTI-TNFα ANTIBODIES AND METHODS OF USE |
| 04/16/2009 | WO2007018853A3 Secretion of antibodies without signal peptides from bacteria |
| 04/16/2009 | WO2007005715A3 Staphylococcal antibodies which cross-react with fungal antigens |
| 04/16/2009 | WO2006138694A3 Rabbit monoclonal antibody against id1 protein |
| 04/16/2009 | WO2006119291A3 Superantibody synthesis and use in detection, prevention and treatment of disease |
| 04/16/2009 | WO2006113665A3 Covalent diabodies and uses thereof |
| 04/16/2009 | WO2006102547A3 Method for purifying proteins |
| 04/16/2009 | WO2006083276A3 Interferon-alpha polypeptides and conjugates |
| 04/16/2009 | WO2006081462A3 Multi-component inhibitors of nucleic acid polymerases |
| 04/16/2009 | WO2006063116A3 Bifunctional enzyme with ϝ-glutamyleysteine synthetase and glutathione synthetase activity and uses thereof |
| 04/16/2009 | WO2006058043A3 Contraceptive vaccines for dogs and cats based on egg membrane antigens |
| 04/16/2009 | WO2006054167A3 Biosensor for detection of camp levels and methods of use |
| 04/16/2009 | WO2006052814A3 A mortierella alpina diacylglycerol acyltransferase for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 04/16/2009 | WO2006042327A3 Plant-produced recombinant aprotinin and aprotinin variants |
| 04/16/2009 | WO2006034356A3 Cardiac pressure overload associated genes |
| 04/16/2009 | WO2006032016A3 P49/strap is a novel protein involved in gene regulation and cell proliferation |
| 04/16/2009 | WO2006023972A3 cAMP REPORTERS |
| 04/16/2009 | WO2006019876A3 Production of fusion proteins by cell-free protein synthesis |
| 04/16/2009 | WO2005115477A3 Non-natural ribonuclease conjugates as cytotoxic agents |
| 04/16/2009 | WO2005056761A3 REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi |
| 04/16/2009 | WO2005042720A3 Kahalalide-producing bacteria |
| 04/16/2009 | WO2005035713A3 Alternatively spliced variants of human cox1 |
| 04/16/2009 | WO2005021705A9 Citrus sesquiterpene synthase, methods of production and uses thereof |
| 04/16/2009 | WO2004039956A3 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | US20090100543 Axmi-018, axmi-020, and axmi-021, a family of delta-endotoxin genes and methods for their use |
| 04/16/2009 | US20090100535 nucleic acids encoding a chimeric protein comprising a cleavage domain and a composite nucleic acid-binding region, that comprises at least two component polypeptide portions which are individually capable of binding specific nucleotide sequences |
| 04/16/2009 | US20090100533 Expression of gamma-carboxylated polypeptides in gamma-carboxylation deficient host sytems |
| 04/16/2009 | US20090099341 Heparanase specific molecular probes and their use in research and medical applications |
| 04/16/2009 | US20090099338 Novel Protein Highly Producing Recombinant Animal Cell, Method for Preparing the Same, and Method for Mass-Producing Protein Using the Same |
| 04/16/2009 | US20090099336 using the conjugates in the inhibition of cell growth; cancer; monoclonal antibody or epitope-binding fragment thereof, that recognizes and binds the CA6 glycotope |
| 04/16/2009 | US20090099193 Eml4-alk fusion gene |
| 04/16/2009 | US20090099107 Methods and Compositions for Inhibition of Nuclear Factor kappaB |
| 04/16/2009 | US20090099081 Synthetic axmi-004 delta-endotoxin genes and methods for their use |
| 04/16/2009 | US20090099079 Novel Fungal Enzymes |
| 04/16/2009 | US20090099073 Albumin Fusion Proteins |
| 04/16/2009 | US20090099071 Sugar chain-containing albumin, production method thereof and use thereof |
| 04/16/2009 | US20090099056 Protease Variants and Compositions |
| 04/16/2009 | US20090099028 Protein binding miniature proteins and uses thereof |
| 04/16/2009 | US20090098634 Scleroprotein of an adeno associated virus with modified chromatographic properties, the production thereof and use of the same |
| 04/16/2009 | US20090098610 useful as a reagent for genetic engineering, DNA sequencing, labeling, site-directed mutagenesi; culturing a cell capable of producing a polypeptide, and collecting such polypeptide from the culture |
| 04/16/2009 | US20090098609 Il-2 fusion proteins with modulated selectivity |
| 04/16/2009 | US20090098608 Methods, systems and reagents for improved immunodetection |
| 04/16/2009 | US20090098607 Production of recombinant human hemoglobin using pichia yeast |
| 04/16/2009 | US20090098606 Cultivating mutant Bacillus licheniformis cell transformed with nucleic acid construct comprising nucleic acid directing synthesis of heterologous protein in suitable medium, where mutant cell comprises deletion mutation in cypX gene or yvmC gene in which mutation renders cell deficient in red pigment |
| 04/16/2009 | US20090098605 MUTATED TRUNCATED mt-pfkA GENE FOR THE SYNTHESIS OF ACTIVE SHORTER FRAGMENT OF 6-PHOSPHOFRUCTO-1-KINASE |
| 04/16/2009 | US20090098604 host cells; tumor antigens; for treatment, prevention of cancer |
| 04/16/2009 | US20090098603 Polypeptides sharing sequence identity with a fibroblast growth factor polypeptide and nucleic acids encoding the same |
| 04/16/2009 | US20090098602 nucleic acid sequence encoding mHKcel; used as an additive in a detergent composition, in the treatment of cellulose containing fabrics, in the treatment of pulp and paper and in the treatment of starch for the production of high fructose corn-syrup or ethanol |
| 04/16/2009 | US20090098601 Selection of Host Cells Expressing Protein at High Levels |
| 04/16/2009 | US20090098600 Thermotolerant ribonuclease h |
| 04/16/2009 | US20090098599 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
| 04/16/2009 | US20090098592 Method |
| 04/16/2009 | US20090098583 Methods of detecting early renal disease in animals |
| 04/16/2009 | US20090098571 Methods and substances for the diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 04/16/2009 | US20090098569 Novel PGC-1 Isoforms and Uses Therefor |
| 04/16/2009 | US20090098544 Marker molecules associated with lung tumors |
| 04/16/2009 | US20090098528 Method for determining early HCV seroconversion |
| 04/16/2009 | US20090098249 Variant Buttiauxella sp. Phytases having altered properties |
| 04/16/2009 | US20090098167 PHL P 1 Allergen Derivative |
| 04/16/2009 | US20090098148 High efficiency tissue-specific compound delivery system using streptavadin-protein a fusion protein |
| 04/16/2009 | US20090098132 Composition and method for treating lupus nephritis |
| 04/16/2009 | US20090098128 NPC1L1 orthologues |
| 04/16/2009 | US20090098122 sRAGE Mimetibody, Compositions, Methods and Uses |
| 04/16/2009 | US20090098120 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | US20090098119 Antidotes for factor xa inhibitors and methods of using the same |
| 04/16/2009 | US20090098051 Bacillus thuringiensis toxin |
| 04/16/2009 | CA2702120A1 Compositions and methods for improved glycoprotein sialylation |
| 04/16/2009 | CA2698326A1 Antibody targeting osteoclast-related protein siglec-15 |
| 04/15/2009 | EP2048505A2 Method for early recognition of the seroconversion of an antibody to hepatitis C |
| 04/15/2009 | EP2048235A2 Synthetic Mammalian Alpha-N-Acetylglucosaminidase and Genetic Sequences Encoding Same |
| 04/15/2009 | EP2048234A1 Chromatographic method for purification of albumin |
| 04/15/2009 | EP2048233A1 MUTANT SepRS, AND METHOD FOR SITE-SPECIFIC INTRODUCTION OF PHOSPHOSERINE INTO PROTEIN BY USING THE SAME |
| 04/15/2009 | EP2048230A1 Cell death inducer |
| 04/15/2009 | EP2048229A1 Human artificial chromosome (hac) vector, and human cell pharmaceutical comprising human artificial chromosome (hac) vector |
| 04/15/2009 | EP2048163A1 Antihuman alpha- 9 integrin antibody and use of the same |
| 04/15/2009 | EP2048162A1 Novel monoclonal antibody and use of the same |
| 04/15/2009 | EP2048161A1 Monoclonal antibody to soluble lox-1 |
| 04/15/2009 | EP2048157A1 Polynucleotide encoding the rg1 polypeptide |
| 04/15/2009 | EP2048155A1 Method and means for the production of pharmaceutically active natural products |
| 04/15/2009 | EP2047862A1 Remedy for renal disease |
| 04/15/2009 | EP2046970A1 A method of producing recombinant biological products |
| 04/15/2009 | EP2046834A1 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |